![Jan Schmidt-Brand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Schmidt-Brand
Corporate Officer/Principal presso BIOPRO Baden-Württemberg GmbH
Profilo
Jan Schmidt-Brand currently works at BIOPRO Baden-Württemberg GmbH, as Deputy Member-Supervisory Board.
Dr. Schmidt-Brand also formerly worked at Heidelberg Pharma AG, as Chief Executive Officer from 2023 to 2024, BIO Deutschland, as Director & Head-Finance & Tax from 2007 to 2019, EBEWE Arzneimittel GmbH, as Managing Director from 1997 to 2001, Heidelberg Pharma Research GmbH, as Managing Director from 2004 to 2024, BASF SE, as Principal, Knoll AG, as Principal, and Heidelberg Pharma AG, as Chief Executive & Financial Officer.
Dr. Schmidt-Brand received his doctorate degree from the University of Mannheim.
Posizioni attive di Jan Schmidt-Brand
Società | Posizione | Inizio |
---|---|---|
BIOPRO Baden-Württemberg GmbH
![]() BIOPRO Baden-Württemberg GmbH Miscellaneous Commercial ServicesCommercial Services BIOPRO Baden-Württemberg GmbH provides business support services to research institutions. | Corporate Officer/Principal | - |
Precedenti posizioni note di Jan Schmidt-Brand
Società | Posizione | Fine |
---|---|---|
Heidelberg Pharma Research GmbH
![]() Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Amministratore Delegato | 01/02/2024 |
HEIDELBERG PHARMA AG | Amministratore Delegato | 01/02/2024 |
BIO Deutschland
![]() BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Direttore Finanziario/CFO | 01/01/2019 |
EBEWE Arzneimittel GmbH | Amministratore Delegato | 01/01/2001 |
Knoll AG
![]() Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Corporate Officer/Principal | - |
Formazione di Jan Schmidt-Brand
University of Mannheim | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BASF SE | Producer Manufacturing |
HEIDELBERG PHARMA AG | Health Technology |
Aziende private | 6 |
---|---|
Knoll AG
![]() Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Health Technology |
BIO Deutschland
![]() BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Commercial Services |
EBEWE Arzneimittel GmbH | |
BIOPRO Baden-Württemberg GmbH
![]() BIOPRO Baden-Württemberg GmbH Miscellaneous Commercial ServicesCommercial Services BIOPRO Baden-Württemberg GmbH provides business support services to research institutions. | Commercial Services |
Heidelberg Pharma Research GmbH
![]() Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Commercial Services |
Heidelberg Pharma AG /Old/
![]() Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Jan Schmidt-Brand